ni.
去 1 gxedmfn
Patent Law Changes Pose Threat to I-Mab Adr’s Drug Candidate Protection
I-Mab Adr (IMAB) has disclosed a new risk, in the Trade Secrets category. The evolving landscape of U.S. patent law presents a significant risk to ...
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论